Letrozole
Insulin Sensitivity
University of VirginiaSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 56/ 100
- Competitive Position
- 89/ 100
Competitive context
2 Active assets in the Insulin Sensitivity cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Levonorgestrel Federico II University | Phase 3 | B |
ORSYTHIA COMPONENT ETHINYL ESTRADIOL Federico II University | Phase 3 | B |
METAMIZOLE Universidad Santo Tomas | N/A | D |
NEPENTHE Universidad Santo Tomas | N/A | D |
Bifidobacterium Bogomolets National Medical University | N/A | D |
View all 13 →
Same molecule, other indications
Letrozole is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →